160
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Synergistic Anticancer Strategy of Sonodynamic Therapy Combined with PI-103 Against Hepatocellular Carcinoma

, , , &
Pages 531-542 | Published online: 11 Feb 2021

References

  • VillanuevaA, LongoDL. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra171326330970190
  • MaS, SunJ, GuoY, et al. Combination of AAV-TRAIL with miR-221-zip therapeutic strategy overcomes the resistance to TRAIL induced apoptosis in liver cancer. Theranostics. 2017;7(13):3228–3242. doi:10.7150/thno.1989328900506
  • YumitaN, NishigakiR, UmemuraK, UmemuraS. Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. Jpn J Cancer Res. 1989;80(3):219–222. doi:10.1111/j.1349-7006.1989.tb02295.x2470713
  • PanX, BaiL, WangH, et al. Metal-organic-framework-derived carbon nanostructure augmented sonodynamic cancer therapy. Adv Mater. 2018;30(23):e1800180. doi:10.1002/adma.20180018029672956
  • ZhuP, ChenY, ShiJ. Nanoenzyme-augmented cancer sonodynamic therapy by catalytic tumor oxygenation. ACS Nano. 2018;12(4):3780–3795. doi:10.1021/acsnano.8b0099929613770
  • LinX, SongJ, ChenX, YangH. Ultrasound-activated sensitizers and applications. Angew Chem Int Ed Engl. 2019.
  • LiX, ZhaoX, PardhiD, et al. Folic acid modified cell membrane capsules encapsulating doxorubicin and indocyanine green for highly effective combinational therapy in vivo. Acta Biomater. 2018;74:374–384. doi:10.1016/j.actbio.2018.05.00629734009
  • HouX, ZhouH, WangL, et al. Multifunctional near-infrared dye-magnetic nanoparticles for bioimaging and cancer therapy. Cancer Lett. 2017;390:168–175. doi:10.1016/j.canlet.2016.12.02628040545
  • ChenQ, LiangC, WangC, LiuZ. An imagable and photothermal “abraxane-like” nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors. Adv Mater. 2015;27(5):903–910. doi:10.1002/adma.20140430825504416
  • LiaoJ, WeiX, RanB, PengJ, QuY, QianZ. Polymer hybrid magnetic nanocapsules encapsulating IR820 and PTX for external magnetic field-guided tumor targeting and multifunctional theranostics. Nanoscale. 2017;9(7):2479–2491. doi:10.1039/C7NR00033B28150848
  • De CockI, ZagatoE, BraeckmansK, et al. Ultrasound and microbubble mediated drug delivery: acoustic pressure as determinant for uptake via membrane pores or endocytosis. J Control Release. 2015;197:20–28. doi:10.1016/j.jconrel.2014.10.03125449801
  • KimJ, JoC, LimWG, et al. Programmed nanoparticle-loaded nanoparticles for deep-penetrating 3d cancer therapy. Adv Mater. 2018;e1707557.29774603
  • LiuY, ZhangD, QiaoZY, et al. A peptide-network weaved nanoplatform with tumor microenvironment responsiveness and deep tissue penetration capability for cancer therapy. Adv Mater. 2015;27(34):5034–5042. doi:10.1002/adma.20150150226198072
  • DongC, JiangQ, QianX, et al. A self-assembled carrier-free nanosonosensitizer for photoacoustic imaging-guided synergistic chemo-sonodynamic cancer therapy. Nanoscale. 2020;12(9):5587–5600. doi:10.1039/C9NR10735E32100776
  • RebouissouS, NaultJC. Advances in molecular classification and precision oncology in hepatocellular carcinoma. J Hepatol. 2020;72(2):215–229. doi:10.1016/j.jhep.2019.08.01731954487
  • TanJL, LiF, YeoJZ, et al. New high-throughput screening identifies compounds that reduce viability specifically in liver cancer cells that express high levels of SALL4 by inhibiting oxidative phosphorylation. Gastroenterology. 2019;157(6):1615–1629.e17. doi:10.1053/j.gastro.2019.08.02231446059
  • YaoW, LinZ, ShiP, et al. Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cells. Biochem Pharmacol. 2020;171:113680. doi:10.1016/j.bcp.2019.11368031669234
  • TinkovS, WinterG, CoesterC, BekeredjianR. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: part I–formulation development and in-vitro characterization. J Control Release. 2010;143(1):143–150. doi:10.1016/j.jconrel.2009.12.02620060861
  • ChouTC, MotzerRJ, TongY, BoslGJ. Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design. J Natl Cancer Inst. 1994;86(20):1517–1524. doi:10.1093/jnci/86.20.15177932806
  • SmileyST, ReersM, Mottola-HartshornC, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A. 1991;88(9):3671–3675. doi:10.1073/pnas.88.9.36712023917
  • SuZ, YangZ, XuY, ChenY, YuQ. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer. 2015;14(1):48. doi:10.1186/s12943-015-0321-525743109
  • YuL, XuF, GaoL. Predict new therapeutic drugs for hepatocellular carcinoma based on gene mutation and expression. Front Bioeng Biotechnol. 2020;8:8. doi:10.3389/fbioe.2020.0000832047745
  • LiG, WangS, DengD, et al. Fluorinated chitosan to enhance transmucosal delivery of sonosensitizer-conjugated catalase for sonodynamic bladder cancer treatment post-intravesical instillation. ACS Nano. 2020;14(2):1586–1599. doi:10.1021/acsnano.9b0668932011860
  • ZhuangD, HanJ, BiL, et al. Sonodynamic effect of hematoporphyrin monomethyl ether on ligature-induced periodontitis in rats. Drug Des Devel Ther. 2015;9:2545–2551. doi:10.2147/DDDT.S82347
  • SonS, KimJH, WangX, et al. Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem Soc Rev. 2020;49(11):3244–3261. doi:10.1039/C9CS00648F32337527
  • GanH, ChenL, SuiX, et al. Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma. Mater Sci Eng C Mater Biol Appl. 2018;91:395–403. doi:10.1016/j.msec.2018.05.01130033270
  • TangX, LyuY, XieD, LiA, LiangY, ZhengD. Therapeutic effect of sorafenib-loaded TPGS-b-PCL nanoparticles on liver cancer. J Biomed Nanotechnol. 2018;14(2):396–403. doi:10.1166/jbn.2018.252931352936
  • ZhangY, XieC, LiA, et al. PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway. Am J Transl Res. 2019;11(8):5134–5149.31497229
  • TangX, ChenL, LiA, et al. Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma. Drug Deliv. 2018;25(1):1484–1494. doi:10.1080/10717544.2018.147785929916268
  • MaA, ChenH, CuiY, et al. Metalloporphyrin complex-based nanosonosensitizers for deep-tissue tumor theranostics by noninvasive sonodynamic therapy. Small. 2019;15(5):e1804028. doi:10.1002/smll.20180402830589210
  • ChenJ, DingJ, WangY. Sequentially responsive shell-stacked nanoparticles for deep penetration into solid tumors. Adv Mater. 2017;29(32):1701170. doi:10.1002/adma.201701170
  • ShiJ, ChenZ, WangB, WangL, LuT, ZhangZ. Reactive oxygen species-manipulated drug release from a smart envelope-type mesoporous titanium nanovehicle for tumor sonodynamic-chemotherapy. ACS Appl Mater Interfaces. 2015;7(51):28554–28565. doi:10.1021/acsami.5b0993726587885
  • TangX, LiA, XieC, et al. The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway. Nanoscale Res Lett. 2020;15(1):63. doi:10.1186/s11671-020-3289-z32219609
  • JiangS, WangQ, FengM, et al. C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells. Appl Microbiol Biotechnol. 2017;101(4):1535–1546. doi:10.1007/s00253-016-7930-927807662
  • RaynaudFI, EcclesS, ClarkePA, et al. Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases. Cancer Res. 2007;67(12):5840–5850. doi:10.1158/0008-5472.CAN-06-461517575152
  • KnightZA, GonzalezB, FeldmanME, et al. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell. 2006;125(4):733–747. doi:10.1016/j.cell.2006.03.03516647110
  • WuB, LiA, ZhangY, et al. Resistance of hepatocellular carcinoma to sorafenib can be overcome with co-delivery of PI3K/mTOR inhibitor BEZ235 and sorafenib in nanoparticles. Expert Opin Drug Deliv. 2020;17(4):573–587. doi:10.1080/17425247.2020.173080932056461
  • PanX, WangH, WangS, et al. Sonodynamic therapy (SDT): a novel strategy for cancer nanotheranostics. Sci China Life Sci. 2018;61(4):415–426. doi:10.1007/s11427-017-9262-x29666990
  • MauryaAK, VinayakM. PI-103 attenuates PI3K-AKT signaling and induces apoptosis in murineT-cell lymphoma. Leuk Lymphoma. 2017;58(5):1153–1161. doi:10.1080/10428194.2016.122520727658642
  • KroemerG, GalluzziL, BrennerC. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007;87(1):99–163.17237344
  • LiW, LiuY, WangB, et al. Protective effect of berberine against oxidative stress-induced apoptosis in rat bone marrow-derived mesenchymal stem cells. Exp Ther Med. 2016;12(6):4041–4048. doi:10.3892/etm.2016.386628101183
  • ZhangX, GibhardtCS, WillT, et al. Redox signals at the ER-mitochondria interface control melanoma progression. EMBO J. 2019;38(15):e100871. doi:10.15252/embj.201810087131304984